FDA’s top drug regulator resigns
Digest more
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
The FDA has sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable ...
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on ...
Image by Tung Lam from Pixabay 6, 2025 - The U.S. Food and Drug Administration has issued 18 warning letters to owners of ...
FDA issues Class II recall for ADHD drug after quality concerns, with millions of prescriptions potentially impacted.
Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...
The Food and Drug Administration said it was taking action after receiving reports of injuries in connection with the products, including toxic side effects.
The Food and Drug Administration has initiated a Class II recall of 141,984 bottles of atorvastatin calcium after tests ...
The complete response letter has not yet been posted to the FDA website, but according to Biohaven, the agency rejected its ...
The dramatic shift in oversight comes at a time when the U.S. has never been more reliant on foreign food, which accounts for ...
The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback